NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NASDAQ:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that the Company will be exhibiting and presenting at the BIO International Convention held in San Diego, California, June 17-20, 2008 (Booth #1224). William R. Prather RPh, MD, Pluristem’s Senior Vice President of Corporate Development will present on June 18 at 1:40 PM. The title of the presentation is “The Clinical Application of 3D Expanded Placental-derived Mesenchymal Stromal Cells.”
